NCT00882336已完成不适用
Epidemiological Study of European Cardiovascular Risk Patients: Disease Prevention and Management in Usual Daily Practice
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 7,200
- 试验地点
- 1
- 主要终点
- LDL-cholesterol, systolic and diastolic blood pressure, Tot. cholesterol, Non-HDL cholesterol, HDL-cholesterol, waist and hip circumference, HbA1c
研究概览
简要总结
The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries.
The patient's participation consists of a single study visit during a routine visit of the patient to the clinic/office.
Study variables will be measured:
- By an interview between physician and patient during the visit and/or available medical records' information: social and demographic patient characteristics, relevant family medical history, current medication.
- By questions asked to the physician: physician perception of patients' CV risk factor, guidelines adherence and cost-containment.
- By measurement performed to the patient during the visit: weight, height, BMI, waist and hip circumference will be measured.
- CV risk factors (blood parameters) will be measured by collecting available data documented within the last year in the medical records and by the collection and analyses of a blood sample during the visit.
研究设计
- 研究类型
- Observational
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 50 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Provision of informed consent.
- •Patients 50+ years old, with at least one additional CV risk factor (with no previous CV event or hospitalisation for a CV event) from Primary Care or hospital outpatient clinic.
排除标准
- •Subjects who are unwilling or unable to provide informed consent
- •Previous CV disease event or hospitalisation for a CV event
- •Current participation in a clinical trial
结局指标
主要结局
LDL-cholesterol, systolic and diastolic blood pressure, Tot. cholesterol, Non-HDL cholesterol, HDL-cholesterol, waist and hip circumference, HbA1c
时间窗: Cross-sectional
Gender, age, patients with diabetes and/or hypertension (%), smoker status, family medical history.
时间窗: Cross-sectional
次要结局
- Biomarkers: Apo-A1, Apo-B, Hs-CRP, Creatinine, albuminuria, uric acid, glomerular filtration rate.(Cross-sectional)
- BMI, Score based 10 year CHD mortality > 5%, High Risk patients (no. and %)(Cross-sectional)
- Use of concomitant medication: anticoagulant, anti hypertensive, antidiabetic, lipid-lowering drugs(Cross-sectional)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Cardiovascular Risk Stratification in Patients With Obstructive Sleep ApneaObstructive Sleep ApneaObesityNCT00768625Associacao Fundo de Incentivo a Psicofarmcologia2,000
进行中(未招募)
不适用
Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint ReplacementThromboembolismAnticoagulant-induced BleedingNCT06627933I.M. Sechenov First Moscow State Medical University1,733
招募中
不适用
Precision Medicine in Cardiovascular Surgery Associated Acute Kidney InjurySurgery-ComplicationsFrailtyAcute Kidney InjuryNCT06471621Insel Gruppe AG, University Hospital Bern100
Unknown
不适用
Cardiovascular Risk in Toledo PopulationCardiovascular Risk FactorCardiovascular DiseasesNCT03294369Castilla-La Mancha Health Service3,125
进行中(未招募)
不适用
European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)Coronary DiseaseST Elevation Myocardial InfarctionNon-ST Elevation Myocardial InfarctionUnstable AnginaAcute Coronary SyndromeNCT06495177European Society of Cardiology8,000
